Featured Research

from universities, journals, and other organizations

OHSU Researchers Discover Breast Cancer Gene Inhibitor

Date:
September 15, 1999
Source:
Oregon Health Sciences University
Summary:
Researchers at Oregon Health Sciences University and the Vollum Institute have discovered a naturally occurring protein that inhibits the functions of the HER-2 oncogene, a major factor in breast and other cancers.

After Years of Study, Protein is Found that Blocks Activity of HER-2 Gene

Portland, Ore. - Researchers at Oregon Health Sciences University and the Vollum Institute have discovered a naturally occurring protein that inhibits the functions of the HER-2 oncogene, a major factor in breast and other cancers. The protein, dubbed herstatin, blocks the HER-2 signaling activity that causes tumor cells to grow, ultimately killing those cells. The findings are reported in the September issue of Proceedings of the National Academy of Sciences.

"This particular gene, HER-2, has such a clear-cut role in breast cancer that if you can inhibit its biochemical activity, you should be able to control the cancer," said Gail Clinton, Ph.D., associate professor of biochemistry and molecular biology at OHSU's School of Medicine.

Clinton and her former student, Joni Doherty, M.D., Ph.D., discovered herstatin while investigating the reasons why HER-2 acts so aggressively in tumor development. An overabundance of HER-2 is present in 25 to 30 percent of breast cancer cases and results in significantly lower survival rates and shorter time to relapse. Besides breast cancer, HER-2 is strongly linked to ovarian, gastric, endometrial and salivary gland cancers and possibly to prostate and colon cancers.

Although the HER-2 oncogene was discovered nearly 20 years ago, and has been studied intensely by scientists around the world, herstatin is the first naturally occurring molecule found to inhibit HER-2. During their research, Clinton and Doherty uncovered a novel mechanism for generation of a HER-2 binding protein resulting in the discovery of herstatin. Because their work involved human cells in culture, there is promise that the protein can be developed into a treatment.

"It's a long way from cells in culture to treating patients, but we are very optimistic about our findings," Clinton said. In addition to Doherty, who is now a surgical fellow at the University of Southern California, other researchers involved were John Adelman, Ph.D., and Chris Bond, M.S., of the Vollum Institute and Armando Jardim, Ph.D., of OHSU.


Story Source:

The above story is based on materials provided by Oregon Health Sciences University. Note: Materials may be edited for content and length.


Cite This Page:

Oregon Health Sciences University. "OHSU Researchers Discover Breast Cancer Gene Inhibitor." ScienceDaily. ScienceDaily, 15 September 1999. <www.sciencedaily.com/releases/1999/09/990915080618.htm>.
Oregon Health Sciences University. (1999, September 15). OHSU Researchers Discover Breast Cancer Gene Inhibitor. ScienceDaily. Retrieved July 24, 2014 from www.sciencedaily.com/releases/1999/09/990915080618.htm
Oregon Health Sciences University. "OHSU Researchers Discover Breast Cancer Gene Inhibitor." ScienceDaily. www.sciencedaily.com/releases/1999/09/990915080618.htm (accessed July 24, 2014).

Share This




More Health & Medicine News

Thursday, July 24, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com
Condemned Man's US Execution Takes Nearly Two Hours

Condemned Man's US Execution Takes Nearly Two Hours

AFP (July 24, 2014) America's death penalty debate raged Thursday after it took nearly two hours for Arizona to execute a prisoner who lost a Supreme Court battle challenging the experimental lethal drug cocktail. Duration: 00:55 Video provided by AFP
Powered by NewsLook.com
China's Ageing Millions Look Forward to Bleak Future

China's Ageing Millions Look Forward to Bleak Future

AFP (July 24, 2014) China's elderly population is expanding so quickly that children struggle to look after them, pushing them to do something unexpected in Chinese society- move their parents into a nursing home. Duration: 02:07 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

    Health News

      Environment News

        Technology News



          Save/Print:
          Share:

          Free Subscriptions


          Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

          Get Social & Mobile


          Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

          Have Feedback?


          Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
          Mobile: iPhone Android Web
          Follow: Facebook Twitter Google+
          Subscribe: RSS Feeds Email Newsletters
          Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins